相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Pulmonary veno-occlusive disease: a probably underdiagnosed cause of pulmonary hypertension in systemic sclerosis
Ana Catarina Duarte et al.
CLINICAL RHEUMATOLOGY (2020)
Impacts of genomics on the health and social costs of intellectual disability
Brett Doble et al.
JOURNAL OF MEDICAL GENETICS (2020)
Computed tomographic and clinical features of pulmonary veno-occlusive disease: raising the radiologist's awareness
N. Ali et al.
CLINICAL RADIOLOGY (2019)
Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension
Said Hajouli et al.
JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS (2019)
Natural History over 8 Years of Pulmonary Vascular Disease in a Patient Carrying Biallelic EIF2AK4 Mutations
David Montani et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease
Esther J. Nossent et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2018)
Good response to PAH-targeted drugs in a PVOD patient carrying Biallelic EIF2AK4 mutation
Li Liang et al.
RESPIRATORY RESEARCH (2018)
Whole-exome sequencing improves genetic testing accuracy in pulmonary artery hypertension
Xiaofang Zeng et al.
PULMONARY CIRCULATION (2018)
Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension
Charaka Hadinnapola et al.
CIRCULATION (2017)
EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial Hypertension
D. Hunter Best et al.
CHEST (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Genetic counselling in a national referral centre for pulmonary hypertension
Barbara Girerd et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Small Sample Lung Biopsy Findings in Patients With Clinicoradiologic Suspicion of Pulmonary Venoocclusive Disease-Pulmonary Capillary Hemangiomatosis
Shakti K. Bal et al.
JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY (2016)
EIF2AK4 mutation as second hit in hereditary pulmonary arterial hypertension
Christina A. Eichstaedt et al.
RESPIRATORY RESEARCH (2016)
Patent Ductus Arteriosus With Eisenmenger Syndrome: Difficult Diagnosis Made Easily With Saline Contrast Echocardiography
Prakash Kumar et al.
CARDIOLOGY RESEARCH (2016)
A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies
J. Tenorio et al.
CLINICAL GENETICS (2015)
The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity
Buvana Ravishankar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension
Melanie Eyries et al.
NATURE GENETICS (2014)
Epidemiology of Pulmonary Arterial Hypertension
Xin Jiang et al.
CURRENT HYPERTENSION REPORTS (2013)
Pulmonary veno-occlusive disease
D. Montani et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Pulmonary veno-occlusive disease -: Clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology
David Montani et al.
MEDICINE (2008)
Structural basis for autoinhibition and mutational activation of eukaryotic initiation factor 2α protein kinase GCN2
AK Padyana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)